Real-world Safety and Efficacy of Teclistamab in Relapsed/refractory Multiple Myeloma: Results from a Multicenter, Retrospective Study and Descriptive Meta-Analysis
LEUKEMIA & LYMPHOMA（2025）
关键词
RRMM,multiple myeloma,teclistamab,real-world,relapsed/refractory,bispecific antibody
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要